Combination Therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: A Series of 116 Consecutive Patients

Abstract

Background: Antibiotics are frequently used to treat hidradenitis suppurativa (HS); however, few data on their efficacy are available. Objective: To evaluate the efficacy of a combination of systemic clindamycin (300 mg twice daily) and rifampicin (600 mg daily) in the treatment of patients with severe HS. Methods: Patients (n = 116) who received this combination were studied retrospectively. The main outcome measure was the severity of the disease, assessed by the Sartorius score, before and after 10 weeks of treatment. Results: The Sartorius score dramatically improved at the end of treatment (median = 29, interquartile range = 14.5, vs. median = 14.5, interquartile range = 11; p < 0.001), as did other parameters of severity as well as the quality of life score. Eight patients (6.9%) stopped the treatment because of side effects. Conclusion: The combination of clindamycin and rifampicin is effective in the treatment of severe HS.

Promising long-term outcomes of the reused skin-graft technique for chronic gluteal hidradenitis suppurativa

“…Chronic lesions, on the other hand, can be treated in a number of ways, including antibiotics 3,4,17,18 , hormones 19 and biologics 20,21 . However, non-surgical approaches provide only temporary improvement and relief.…”

Hidradenitis suppurativa: why isn’t it a form of acne?

“…formájában javasoltak. Három retrospektív (n=116) és egy prospektív (n=23) klinikai vizsgálat során clindamycin és rifampicin kombinációjával a betegek 80-85%-ánál észleltek klinikai választ (33)(34)(35)(36). A kezelések során jelentkező leggyakoribb mellékhatás (13-22%) gasztrointesztinális jellegű volt.…”

La maladie de Verneuil : à propos de 107 cas

“…Le traitement médical repose sur les soins locaux, les traitements antiseptiques, et l'antibiothérapie. La combinaison clindamycine et rifampicine à la dose de 600 mg par jour a été évaluée récemment dans deux séries [15][16]. Elle n'a pas été utilisé chez nos malades car la clindamycine n'est pas disponible au Maroc et la rifampicine utilisée exclusivement comme un antituberculeux pour.…”